161 research outputs found
Predictors of Caregiver Communication About Reproductive and Sexual Health and Sensitive Sex Topics
Numerous studies examining parentâteen communication about sex (PTCS) have focused on reproductive and sexual health information (i.e., pregnancy, physical development, contraception), with significantly fewer addressing communication about sensitive sex topics (i.e., sexual pleasure, masturbation). This study compares predictors of communication about reproductive and sexual health to those of sensitive sex topics with early adolescents. Participants were 465 rural caregivers and their African American youth. Positive attitudes and self-efficacy for PTCS, open communication style, and older youth age predicted caregiver reports of communication about reproductive and sexual health topics. Open communication style and self-efficacy for PTCS predicted caregiver reports of communication about sensitive sex topics. For youth, only older age and being female predicted communication about reproductive and sexual health, while only being female predicted communication about sensitive sex topics. This study may inform interventions that seek to increase PTCS by highlighting strategies for improving communication about both reproductive and sensitive sex topics
How Does Pubertal Development Impact Caregiver-Adolescent Communication About Sex in Rural, African American Families? An Examination of Mediation Effects
This study examined the relationship between pubertal development and type of caregiver-adolescent communication about sex (CACS) among 441 African American caregivers participating in an intervention trial in rural North Carolina. We assessed CACS about general sexual health topics and positive aspects of sexuality. Caregiversâ attitudes and self-efficacy for CACS, and open communication style were examined as potential mediators. Caregivers engaged in low levels of communication about sex regardless of type. Among caregivers of males, pubertal development was associated with greater communication about general sexual health, which was mediated by self-efficacy for CACS. Among caregivers of females, pubertal development was associated with less communication about general and positive sexual health topics; however, there were no mediating factors. These findings highlight the predictors of CACS among young men and women after pubertal onset. Age appropriate, practical guidance for initiating CACS may be critical for ensuring caregiver talk about sex
Understanding the Relationship between Religiosity and CaregiverâAdolescent Communication About Sex within African-American Families
Caregiverâadolescent communication about sex plays a critical role in the sexual socialization of youth. Many caregivers, however, do not engage their youth in such conversations, potentially placing them at risk for negative sexual health outcomes. Lack of caregiverâadolescent communication about sex may be particularly harmful for rural African American youth, as they often report early sex initiation and are disproportionately impacted by STIs. Moreover, sexual communication may be particularly challenging for families with strong religious backgrounds, potentially affecting the occurrence and breadth of topics covered during communication. Study aims were to: determine whether there was a relationship between caregiver religiosity and type of topics covered during communication about sex (e.g., general sexual health vs. positive aspects of sexuality) among 435 caregivers of early adolescent, African American youth; and if so, identify factors that might explain how religiosity affects communication about sex. Results indicated that caregiver religiosity was positively associated with communication about general, but not positive aspects of sexuality for caregivers of males. Attitudes towards communication about sex and open communication style mediated the relationship. There was no association between religiosity and communication about sex for caregivers of females. The findings from this study could provide a base to better understand and support the sexual socialization process within religious, African American families
ĐŁŃĐ”Đ±ĐœĐŸ-ĐžŃŃĐ»Đ”ĐŽĐŸĐČĐ°ŃДлŃŃĐșĐ°Ń ŃĐ°Đ±ĐŸŃĐ° ŃŃŃĐŽĐ”ĐœŃĐŸĐČ ĐČ ĐŒĐ”ĐŽĐžŃĐžĐœŃĐșĐŸĐŒ ĐČŃĐ·Đ”
This book constitutes the refereed proceedings of the 11th IFIP WG 8.5 International Conference, EGOV 2012, held in Delft, The Netherlands, in September 2012. The 23 revised full papers presented were carefully reviewed and selected from more then 80 submissions. The papers are organized in topical sections on foundations; adoption and diffusion; open government and transformation; infrastructure and technology; evaluation; and citizen perspective, social inclusion, and social media.
RelaçÔes empĂricas entre caracterĂsticas dendromĂ©tricas da Caatinga brasileira e dados TM Landsat 5
O objetivo deste trabalho foi ajustar modelos para estimar caracterĂsticas dendromĂ©tricas da Caatinga brasileira a partir de dados do sensor TM do Landsat 5. Medidas de diĂąmetro e altura das ĂĄrvores foram obtidas de 60 parcelas de inventĂĄrio (400 m2), em dois municĂpios do Estado de Sergipe. A ĂĄrea basal e o volume de madeira foram estimados com uso de equação alomĂ©trica e de fator de forma (f = 0,9). As variĂĄveis explicativas foram obtidas do sensor TM, apĂłs correção radiomĂ©trica e geomĂ©trica, tendo-se considerado, na anĂĄlise, seis bandas espectrais, com resolução espacial de 30 m, alĂ©m dos Ăndices de razĂŁo simples (SR), de vegetação por diferença normalizada (NDVI) e de vegetação ajustado ao solo (Savi). Na escolha das melhores variĂĄveis explicativas, foram considerados coeficiente de determinação (R2), raiz do erro quadrĂĄtico mĂ©dio (RMSE) e critĂ©rio bayesiano de informação (CBI). A ĂĄrea basal por hectare nĂŁo apresentou correlação significativa com nenhuma das variĂĄveis explicativas utilizadas. Os melhores modelos foram ajustados Ă altura mĂ©dia das ĂĄrvores por parcela (R2 = 0,4; RMSE = 13%) e ao volume de madeira por hectare (R2 = 0,6; RMSE = 42%). As mĂ©tricas derivadas do sensor TM do Landsat 5 tĂȘm grande potencial para explicar variaçÔes de altura mĂ©dia das ĂĄrvores e do volume de madeira por hectare, em remanescentes de Caatinga situados no Nordeste brasileiro
A study of CP violation in B-+/- -> DK +/- and B-+/- -> D pi(+/-) decays with D -> (KSK +/-)-K-0 pi(-/+) final states
A first study of CP violation in the decay modes B-+/- -> [(KSK +/-)-K-0 pi(-/+)](D)h(+/-) and B-+/- -> [(KSK +/-)-K-0 pi(-/+)](D)h(+/-), where h labels a K or pi meson and D labels a D-0 or (D) over bar (0) meson, is performed. The analysis uses the LHCb data set collected in pp collisions, corresponding to an integrated luminosity of 3 fb(-1). The analysis is sensitive to the CP-violating CKM phase gamma through seven observables: one charge asymmetry in each of the four modes and three ratios of the charge-integrated yields. The results are consistent with measurements of gamma using other decay modes
Measurement of Ï production in pp collisions at âs = 2.76 TeV
The production of Ï(1S), Ï(2S) and Ï(3S)
mesons decaying into the dimuon final state is studied with
the LHCb detector using a data sample corresponding to an
integrated luminosity of 3.3 pbâ1 collected in protonâproton
collisions at a centre-of-mass energy of âs = 2.76 TeV. The
differential production cross-sections times dimuon branching
fractions are measured as functions of the Ï transverse
momentum and rapidity, over the ranges pT < 15 GeV/c
and 2.0 < y < 4.5. The total cross-sections in this kinematic
region, assuming unpolarised production, are measured to be
Ï (pp â Ï(1S)X) Ă B
Ï(1S)âÎŒ+ÎŒâ
= 1.111 ± 0.043 ± 0.044 nb,
Ï (pp â Ï(2S)X) Ă B
Ï(2S)âÎŒ+ÎŒâ
= 0.264 ± 0.023 ± 0.011 nb,
Ï (pp â Ï(3S)X) Ă B
Ï(3S)âÎŒ+ÎŒâ
= 0.159 ± 0.020 ± 0.007 nb,
where the first uncertainty is statistical and the second systematic
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.
BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362
- âŠ